Vcheck Blog: Due Diligence Insights for Private Equity
-
Tackling the $3.1 Billion Corporate Fraud Problem with Continuous Monitoring June 6, 2025 Corporate fraud and white-collar crimes disrupt industries and erode public trust. -
Vcheck’s public records research uncovered partnership risks in former professional athlete May 21, 2025 When a leading private equity firm considered investing in a prominent former athlete’s business, Vcheck’s thorough investigation across 15+ jurisdictions uncovered critical red flags.. -
How FinCEN’s New AML/CFT Rule Reshapes Due Diligence for Investment Advisers May 1, 2025 Effective January 1, 2026, this rule closes a gap in financial oversight frameworks by classifying IAs as financial institutions under the Bank Secrecy Act (BSA). IAs will now face full AML/CFT compliance for the first time. -
ExThera Case Exposes Immediate Investor Threat Due to Poor Startup Due Diligence April 22, 2025 In January 2025, The New York Times published an exposé by John Carreyrou on ExThera Medical, a California startup that allegedly repurposed its FDA-authorized COVID-19 blood filter for cancer treatment without regulatory approval. -
Navigating Supply Chain Disruptions Under the EU CSDDD & the Simplification Omnibus April 18, 2025 In effect July 2024, the EU’s Corporate Sustainability Due Diligence Directive (CSDDD) marked a shift in corporate accountability, mandating companies to address human rights abuses, environmental harm, and unethical practices across their supply chains. -
How Vcheck’s IPO due diligence uncovered significant financial risk in potential issuer April 16, 2025 Ahead of a high-profile IPO, a leading investment bank engaged Vcheck to conduct deep-dive background checks on a global healthcare company…